Full Text
Female reproductive health is regulated through a complex interaction of endocrine, metabolic, immunological, and environmental factors that collectively determine fertility, successful implantation, pregnancy maintenance, and fetal development. During recent decades, vitamin D has emerged as an important biological regulator extending far beyond skeletal metabolism. Extensive experimental and clinical investigations have demonstrated that vitamin D actively participates in numerous reproductive processes affecting both maternal and fetal health.
Vitamin D functions as a steroid hormone after undergoing sequential activation within the liver and kidneys. Its biological effects are mediated through the vitamin D receptor, which is widely expressed in reproductive organs including ovarian granulosa cells, endometrial tissue, fallopian tubes, placental trophoblasts, decidua, and the hypothalamic-pituitary axis. Activation of these receptors regulates transcription of genes involved in hormone synthesis, immune tolerance, cellular proliferation, angiogenesis, and embryo implantation.
Adequate vitamin D status contributes to normal ovarian physiology by supporting follicular development and steroid hormone production. It influences granulosa cell differentiation, estrogen biosynthesis, progesterone secretion, and oocyte maturation. Deficiency may impair these physiological mechanisms, leading to ovulatory dysfunction, reduced fertility, and prolonged time to conception. Several investigations have reported lower serum vitamin D concentrations among women with infertility compared with fertile controls.
The relationship between vitamin D deficiency and polycystic ovary syndrome has received particular scientific attention. Women affected by this endocrine disorder frequently demonstrate reduced vitamin D concentrations accompanied by insulin resistance, obesity, chronic inflammation, and menstrual irregularities. Correction of vitamin D deficiency has been associated with improvements in metabolic regulation, menstrual cyclicity, and ovulatory function in selected patient populations.
Vitamin D also appears to influence endometrial receptivity during the implantation window. Appropriate regulation of immune responses at the maternal-fetal interface is essential for successful embryo implantation and maintenance of early pregnancy. Vitamin D contributes to immune tolerance by modulating cytokine production, suppressing excessive inflammatory responses, and promoting development of regulatory immune cells that protect the developing embryo from immunological rejection.
Placental development represents another important biological process influenced by vitamin D. Adequate vitamin D availability supports trophoblast invasion, placental angiogenesis, vascular remodeling, and nutrient transport. Deficiency during early pregnancy may impair placental function and increase susceptibility to pregnancy-related complications including preeclampsia, fetal growth restriction, placental insufficiency, and spontaneous preterm birth.
Maternal vitamin D deficiency has additionally been associated with gestational diabetes mellitus through its effects on pancreatic beta-cell function, insulin secretion, and peripheral insulin sensitivity. Chronic deficiency may contribute to metabolic disturbances that adversely affect both maternal health and fetal development. Furthermore, inadequate vitamin D concentrations have been linked to increased risks of recurrent miscarriage, bacterial vaginosis, cesarean delivery, and postpartum complications.
The fetus depends almost entirely on maternal vitamin D stores during pregnancy. Consequently, maternal deficiency may influence fetal skeletal mineralization, immune maturation, lung development, and neurological development. Increasing evidence also suggests that adequate prenatal vitamin D exposure may reduce the future risk of allergic disorders, autoimmune diseases, respiratory illnesses, and impaired bone health during childhood.
Despite growing recognition of its reproductive importance, vitamin D deficiency remains highly prevalent worldwide due to limited sunlight exposure, nutritional inadequacy, obesity, darker skin pigmentation, chronic diseases, and lifestyle factors. Many women enter pregnancy with insufficient vitamin D reserves, highlighting the importance of preventive screening and early intervention.
The present study aimed to evaluate the role of vitamin D in female reproductive health and pregnancy outcomes by analyzing its association with fertility, endocrine function, placental development, maternal complications, fetal growth, and neonatal health, while emphasizing current approaches to prevention and clinical management.
2. Materials and Methods
This prospective observational study was conducted between January 2023 and March 2025 at the Departments of Obstetrics and Gynecology of tertiary referral hospitals. The primary objective was to evaluate the association between maternal vitamin D status and reproductive health indicators, pregnancy progression, maternal complications, fetal development, and neonatal outcomes.
A total of 240 women of reproductive age participated in the investigation. The study population consisted of two cohorts. The first cohort included 120 women planning pregnancy or receiving infertility evaluation, while the second cohort consisted of 120 pregnant women monitored from the first trimester until delivery. Participants ranged in age from 20 to 40 years and represented diverse socioeconomic and nutritional backgrounds.
Women with chronic renal disease, severe hepatic dysfunction, parathyroid disorders, active malignant disease, multiple pregnancy, or long-term corticosteroid therapy were excluded because these conditions may independently alter vitamin D metabolism and pregnancy outcomes.
Comprehensive demographic and clinical information was collected at enrollment. Variables included maternal age, body mass index, educational status, dietary habits, physical activity, duration of sunlight exposure, smoking status, previous obstetric history, menstrual characteristics, infertility duration where applicable, and pre-existing medical conditions.
Venous blood samples were collected under standardized laboratory conditions. Serum 25-hydroxyvitamin D concentrations were measured using chemiluminescent immunoassay and categorized as sufficient, insufficient, or deficient according to internationally accepted laboratory reference values. Additional laboratory investigations included serum calcium, phosphorus, magnesium, parathyroid hormone, fasting blood glucose, glycated hemoglobin, complete blood count, thyroid function tests, and inflammatory biomarkers when clinically indicated.
Reproductive evaluation included transvaginal ultrasonography to assess ovarian morphology, antral follicle count, endometrial thickness, uterine anatomy, and follicular development. Hormonal assessment included follicle-stimulating hormone, luteinizing hormone, estradiol, progesterone, prolactin, anti-Müllerian hormone, and thyroid-stimulating hormone according to the menstrual cycle phase.
Pregnant participants underwent routine antenatal surveillance throughout gestation. Clinical monitoring included blood pressure measurement, maternal weight gain, glucose tolerance testing, fetal biometric assessment, placental evaluation, Doppler ultrasonography, amniotic fluid assessment, and fetal wellbeing monitoring.
Maternal outcomes evaluated during pregnancy included gestational hypertension, preeclampsia, gestational diabetes mellitus, anemia, threatened miscarriage, premature rupture of membranes, placental insufficiency, preterm labor, and mode of delivery.
Neonatal assessment included gestational age at birth, birth weight, body length, head circumference, Apgar scores, neonatal intensive care admission, respiratory adaptation, and early neonatal complications.
Statistical analysis was performed using internationally accepted biomedical statistical methods. Continuous variables were expressed as mean values with standard deviations, while categorical variables were presented as frequencies and percentages.
Clinical evaluation demonstrated that vitamin D deficiency was highly prevalent among women of reproductive age, particularly among participants with limited sunlight exposure, sedentary lifestyles, obesity, and inadequate dietary intake of vitamin D-rich foods. Reduced serum vitamin D concentrations were observed more frequently in women with infertility and endocrine reproductive disorders than among women with normal reproductive function.
Women presenting with infertility demonstrated significant associations between vitamin D deficiency and impaired ovarian function. Menstrual irregularities, delayed ovulation, diminished ovarian reserve, and prolonged infertility duration occurred more frequently among participants with lower serum vitamin D concentrations. Ultrasonographic examination revealed less favorable follicular maturation and reduced endometrial thickness during the implantation period in women with persistent deficiency.
Among women diagnosed with polycystic ovary syndrome, lower vitamin D concentrations were associated with greater insulin resistance, increased body mass index, menstrual dysfunction, and biochemical hyperandrogenism. Improvement of vitamin D status during clinical follow-up was accompanied by partial restoration of menstrual regularity and improved ovulatory activity in many participants.
Pregnant women with adequate vitamin D concentrations experienced more favorable gestational progression. Placental development appeared more physiological, fetal biometric parameters remained appropriate for gestational age, and maternal metabolic adaptation progressed without significant abnormalities throughout pregnancy.
Conversely, maternal vitamin D deficiency was associated with increased incidence of gestational diabetes mellitus, hypertensive disorders of pregnancy, placental insufficiency, and preterm uterine activity. These complications occurred more frequently during the second and third trimesters and required closer obstetric surveillance.
Ultrasonographic fetal assessment demonstrated that pregnancies complicated by vitamin D deficiency more frequently exhibited reduced fetal growth velocity, lower estimated fetal weight, and evidence of impaired placental circulation during Doppler examination. Although severe fetal complications remained relatively uncommon, subtle growth restriction occurred significantly more often in vitamin D-deficient mothers.
Delivery outcomes also differed between study groups. Women maintaining sufficient vitamin D concentrations experienced higher rates of uncomplicated vaginal delivery, whereas operative delivery and cesarean section occurred more frequently among women with persistent deficiency because of obstetric complications.
Neonatal assessment demonstrated improved birth weight, higher Apgar scores, and fewer early neonatal adaptation problems among infants born to mothers with adequate vitamin D status. Newborns of vitamin D-deficient mothers more commonly required short-term neonatal observation because of transient respiratory adaptation difficulties or low birth weight.
Overall clinical analysis demonstrated that maintenance of adequate maternal vitamin D status before conception and throughout pregnancy was associated with healthier reproductive function, reduced pregnancy complications, improved placental performance, and more favorable neonatal outcomes.
The findings of the present investigation support growing evidence that vitamin D performs essential biological functions throughout female reproduction and pregnancy. Rather than serving exclusively as a regulator of calcium metabolism, vitamin D acts as an endocrine and immunomodulatory factor influencing ovarian physiology, implantation, placental development, maternal immune adaptation, and fetal growth.
The observed relationship between vitamin D deficiency and infertility reflects the broad physiological effects of vitamin D on ovarian steroidogenesis, follicular maturation, and endometrial receptivity. Adequate activation of vitamin D receptors within reproductive tissues appears necessary for optimal reproductive performance and successful conception.
The association between vitamin D deficiency and polycystic ovary syndrome further highlights the interaction between endocrine metabolism and reproductive health. Improvement of insulin sensitivity and modulation of inflammatory pathways may explain the beneficial reproductive effects observed following correction of vitamin D deficiency in women with metabolic reproductive disorders.
During pregnancy, vitamin D contributes to normal placental vascular development, trophoblast differentiation, and regulation of maternal immune tolerance. Deficiency may impair these physiological processes, increasing susceptibility to hypertensive disorders, gestational diabetes, placental insufficiency, and premature delivery.
The favorable neonatal outcomes observed among women with sufficient vitamin D concentrations emphasize the importance of maternal nutritional status during fetal development. Adequate maternal vitamin D availability supports fetal skeletal mineralization, immune maturation, pulmonary development, and healthy neonatal adaptation after birth.
Although vitamin D supplementation alone cannot eliminate every pregnancy complication, optimization of maternal vitamin D status represents a simple, safe, and cost-effective strategy capable of improving maternal and neonatal health. Individualized supplementation based on laboratory assessment and clinical risk factors may provide greater benefit than routine empirical treatment.
Future investigations should include multicenter randomized clinical trials with extended neonatal follow-up to clarify optimal supplementation strategies, determine population-specific dosage requirements, and further explore the molecular mechanisms linking vitamin D with reproductive physiology.
Vitamin D plays a fundamental role in female reproductive health by regulating ovarian function, endocrine balance, implantation, placental development, maternal immune adaptation, and fetal growth. Deficiency is associated with impaired fertility, endocrine dysfunction, increased pregnancy complications, and less favorable neonatal outcomes.
Early identification of vitamin D deficiency before conception and during pregnancy allows timely nutritional intervention that may improve reproductive performance and reduce obstetric risks. Integration of vitamin D assessment into routine reproductive and prenatal care should therefore be considered an important component of comprehensive women's healthcare.
Maintaining adequate vitamin D status through appropriate nutrition, safe sunlight exposure, individualized supplementation, and regular clinical monitoring represents an effective strategy for promoting healthy pregnancy progression and improving maternal as well as neonatal outcomes.
[1] Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357(3):266–281.
[2] Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2011;96(7):1911–1930.
[3] Palacios C, De-Regil LM, Lombardo LK, Peña-Rosas JP. Vitamin D supplementation during pregnancy. Cochrane Database Syst Rev. 2019;(7):CD008873.
[4] Aghajafari F, Nagulesapillai T, Ronksley PE, Tough SC, O'Beirne M, Rabi DM. Association between maternal serum vitamin D levels and pregnancy outcomes: a systematic review and meta-analysis. BMJ. 2013;346:f1169.
[5] Pilz S, Trummer C, Pandis M, et al. Vitamin D: current guidelines and future outlook in reproductive medicine. Nutrients. 2022;14(9):1875.
[6] Lerchbaum E, Obermayer-Pietsch B. Vitamin D and fertility: a systematic review. Eur J Endocrinol. 2012;166(5):765–778.
[7] Irani M, Merhi Z. Role of vitamin D in ovarian physiology and female reproduction. Reprod Biol Endocrinol. 2014;12:142.
[8] Grundmann M, von Versen-Höynck F. Vitamin D – roles in women's reproductive health? Reprod Biol Endocrinol. 2011;9:146.
[9] Chu J, Gallos I, Tobias A, et al. Vitamin D and assisted reproductive treatment outcome: a systematic review and meta-analysis. Hum Reprod. 2018;33(1):65–80.
[10] Bartoli A, Schiuma D, Del Pup L, et al. Vitamin D and pregnancy: impact on maternal and neonatal outcomes. Nutrients. 2023;15(7):1678.
[11] American College of Obstetricians and Gynecologists. Vitamin D: Screening and supplementation during pregnancy. Committee Opinion No. 495 (updated recommendations). Obstet Gynecol. 2024.
[12] Endocrine Society. Clinical Practice Guideline for Vitamin D in Disease Prevention. J Clin Endocrinol Metab. 2024;109(8):1907–1947.
[13] World Health Organization. WHO recommendations on antenatal care for a positive pregnancy experience. Geneva: WHO; Updated 2024.
[14] World Health Organization. Micronutrient supplementation during pregnancy. Geneva: WHO; 2024.
[15] International Federation of Gynecology and Obstetrics (FIGO). Good Clinical Practice Advice: Micronutrients in Pregnancy. Int J Gynaecol Obstet. 2023;161(Suppl 1):1–18.
[16] Institute of Medicine. Dietary Reference Intakes for Calcium and Vitamin D. National Academies Press; 2011.
[17] Cunningham FG, Leveno KJ, Bloom SL, et al. Williams Obstetrics. 27th ed. McGraw-Hill; 2024.
[18] Boggess KA, Berggren EK. Vitamin D and reproductive health: emerging clinical evidence. Fertil Steril. 2021;116(3):615–623.
[19] Med1.uz. D vitamini tanqisligi va ayollar reproduktiv salomatligi. Available from: https://med1.uz/articles/ginekologiya/d-vitamini
[20] Med1.uz. Homiladorlik davrida vitamin D ning ahamiyati. Available from: https://med1.uz/articles/akusherlik/vitamin-d-homiladorlik
[21] Med1.uz. Reproduktiv yoshdagi ayollarda vitamin D yetishmovchiligi. Available from: https://med1.uz/articles/endokrinologiya/vitamin-d
[22] Med1.uz. Homiladorlikda mikroelementlar va vitaminlar. Available from: https://med1.uz/articles/akusherlik/mikroelementlar
[23] Med1.uz. Ayollar bepushtligi va endokrin omillar. Available from: https://med1.uz/articles/ginekologiya/bepushtlik
[24] Med1.uz. Homiladorlik asoratlarining profilaktikasi. Available from: https://med1.uz/articles/akusherlik/profilaktika
[25] Med1.uz. Prenatal parvarishning zamonaviy tamoyillari. Available from: https://med1.uz/articles/akusherlik/prenatal-parvarish
[26] Med1.uz. Ayollar salomatligini saqlashda vitaminlarning o‘rni. Available from: https://med1.uz/articles/ginekologiya/vitaminlar